Is There a Way Forward With Hodgkin's Chemotherapy?

The way forward with Hodgkin is to use checkpoint inhibitors up front. But the crucial difference is at the moment they're just being added to basically the same amount of chemo, six cycles of AAVD or whatever. That's still exposing patients to 300 milligrams per metre squared of docks that has a cardiac implications. What we need to be doing, I think, is using checkpoint inhibitors in a much clever way and start reducing the burden of chemotherapy. So that's where I really see the field, at least in upfront, the frontline field going.